**Site Name**: Oslo
**Posted Date**: Oct 8 2024
GSK has bold commercial ambitions for the future. By 2031, we aim to deliver £38 billion in annual sales - building from existing strong performance momentum which will significantly increase the positive impact we can have on the health of billions of patients around the world. Our Ahead Together strategy means intervening early to prevent and change the course of disease, helping to protect people and support healthcare systems.
Our portfolio is made up of vaccines, specialty medicines and general medicines. These are the three different types of products we create to prevent and treat disease, many with the potential to be first-or best-in-class.
If you are interested in joining us, find out more:
Annual Report 2023
Product Pipeline
**We want you as our Commercial Launch Lead for our exciting Hematology pipeline**
We are seeking a dynamic and strategic Commercial Launch Lead for Hematology to join our team. This...